The efficacy of afatinib and gefitinib as first-line therapy in advanced-stage non-small cell lung cancer (NSCLC) with EGFR mutation-positive in Vietnamese patients
| dc.contributor.advisor | Pham, Van Luan | |
| dc.contributor.author | Nguyen, Dinh Tung | |
| dc.date.accessioned | 2024-08-21T02:41:19Z | |
| dc.date.available | 2024-08-21T02:41:19Z | |
| dc.date.issued | 2024-02-28 | |
| dc.identifier.uri | https://vinspace.edu.vn/handle/VIN/198 | |
| dc.description.abstract | GME | en_US |
| dc.subject | non-small-cell lung cancer | en_US |
| dc.subject | EGFR mutation | en_US |
| dc.subject | afatinib | en_US |
| dc.subject | gefitinib | en_US |
| dc.subject | Vietnamese | en_US |
| dc.title | The efficacy of afatinib and gefitinib as first-line therapy in advanced-stage non-small cell lung cancer (NSCLC) with EGFR mutation-positive in Vietnamese patients | en_US |
| dc.type | Master thesis | en_US |
| dc.relation.title | Mr. | en_US |
| dc.relation.studentnumber | V202000310 | en_US |
| dc.relation.graduation | 2024-10 | |
| dc.relation.email | tungk45hnue@gmail.com | en_US |
| dc.relation.telephone | 0987690481 | en_US |
| dc.relation.college | CHS | en_US |
| dc.relation.major | Internal Medicine | en_US |
| dc.relation.degree | Graduate Medical Education (GME) | en_US |
| dc.relation.availability | Be opened to the public after self-submission. (This option is NOT subject to approval) | en_US |
